InfliximabA Review of its Use in Crohn’s Disease and Rheumatoid Arthritis

[1] Head K(2004)Inflammatory bowel disease Part II: Crohn’s disease-pathophysiology and conventional and alternative treatment options. Altern Med Rev 9 360-401

[2] Jurenka JS(2001)Rheumatoid arthritis Lancet 358 903-11

[3] Lee DM(2004)Biological agents for rheumatoid arthritis: targeting both physical function and structural damage Drugs 64 1267-83

[4] Weinblatt ME(2004)Emerging biologic therapies in inflammatory bowel disease Rev Gastroenterol Disord 4 66-85

[5] Klinkhoff A(1998)Infliximab: a review of its use in Crohn’s disease and rheumatoid arthritis BioDrugs 10 397-422

[6] Lim WC(2002)Infliximab: an updated review of its use in Crohn’s disease and rheumatoid arthritis BioDrugs 16 111-48

[7] Hanauer SB(2000)Infliximab: a review of its use in the management of rheumatoid arthritis Drugs 59 1341-59

[8] Onrust SV(2005)Infliximab: in ankylosing spondylitis Drugs 65 1283-91

[9] Lamb HM(2000)Review article: the clinical role of anti-TNEalpha antibody treatment in Crohn’s disease Aliment Pharmacol Ther 14 501-14

[10] Keating GM(1993)Construction and initial characterization of a mouse-human chimeric anti-TNF antibody Mol Immunol 30 1443-53

[1] Head K(2004)Inflammatory bowel disease Part II: Crohn’s disease-pathophysiology and conventional and alternative treatment options. Altern Med Rev 9 360-401

[2] Jurenka JS(2001)Rheumatoid arthritis Lancet 358 903-11

[3] Lee DM(2004)Biological agents for rheumatoid arthritis: targeting both physical function and structural damage Drugs 64 1267-83

[4] Weinblatt ME(2004)Emerging biologic therapies in inflammatory bowel disease Rev Gastroenterol Disord 4 66-85

[5] Klinkhoff A(1998)Infliximab: a review of its use in Crohn’s disease and rheumatoid arthritis BioDrugs 10 397-422

[6] Lim WC(2002)Infliximab: an updated review of its use in Crohn’s disease and rheumatoid arthritis BioDrugs 16 111-48

[7] Hanauer SB(2000)Infliximab: a review of its use in the management of rheumatoid arthritis Drugs 59 1341-59

[8] Onrust SV(2005)Infliximab: in ankylosing spondylitis Drugs 65 1283-91

[9] Lamb HM(2000)Review article: the clinical role of anti-TNEalpha antibody treatment in Crohn’s disease Aliment Pharmacol Ther 14 501-14

[10] Keating GM(1993)Construction and initial characterization of a mouse-human chimeric anti-TNF antibody Mol Immunol 30 1443-53